Sleep struggles in blistering skin disease: new study investigates
NCT ID NCT07188402
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study measured how often sleep disturbances occur in people with bullous pemphigoid, a blistering skin condition that mostly affects older adults. Researchers compared 122 patients to healthy volunteers using a simple insomnia questionnaire. The goal was to understand if sleep problems are more common in this group, which could help improve overall care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If sleep problems are found to be common in bullous pemphigoid, it could lead to better care that includes sleep management for patients.
- What could go wrong
- This is a small, completed observational study using only a questionnaire. It does not test any treatment, so it cannot directly improve sleep or disease outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
122 people
The number who actually took part.
- Started
-
Aug 2020
- Finished
-
Jan 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Prospective, non-interventional, descriptive, multicenter case-control study based on a questionnaire (ISI questionnaire) aimed at patients with bullous pemphigoid and healthy volunteers, controls recruited during dermatology department consultations, followed for basal cell carcinoma, seborrheic keratosis, actinic keratosis, squamous cell carcinoma or other benign skin tumor known not to affect sleep.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adult Patient 2. Patients: Bullous Pemphigoid: Newly diagnosed by: * Rash suggestive of Bullous Pemphigoid * Histology: Subepidermal bulla or margination of eosinophils along the dermoepidermal junction (DEJ) * Controls: Patient with Basal Cell Carcinoma, Squamous Cell Carcinoma, Seborrheic Keratosis, Actinic Keratosis, or Other Benign Skin Tumor. We selected the control group from these patients because these dermatological conditions do not affect sleep quality. 3. Mini Mental Status Examination (MMS) score \> 20 4. No Formulated Opposition Exclusion Criteria: 1. Protected Adult 2. Advanced Dementia Syndrome
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bullous pemphigoid (BP) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Rouen Hospital
Rouen, 76031, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.